EE200300096A - Arginiini ja selle farmatseutiliselt vastuvõetavate soolade kasutamine, antineoplastilist toimeainet ja arginiini sisaldava intravenoosselt manustatava preparaadi kasutamine, toode või komplekt kasutamiseks vähiravis ja preparaat intravenoosseks manu - Google Patents

Arginiini ja selle farmatseutiliselt vastuvõetavate soolade kasutamine, antineoplastilist toimeainet ja arginiini sisaldava intravenoosselt manustatava preparaadi kasutamine, toode või komplekt kasutamiseks vähiravis ja preparaat intravenoosseks manu

Info

Publication number: EE200300096A
Authority: EE; Estonia
Prior art keywords: arginine; preparation; intravenous; cancer; kit
Prior art date: 2000-09-12

Application number

EEP200300096A

Other languages

English (en)

Inventor

Muggetti Lorena

Martini Alessandro

Buzzi Giovanni

Colombo Paolo

Original Assignee

Pharmacia Italia S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-12

Filing date

2001-09-07

Publication date

2005-02-15

2001-09-07 Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.

2005-02-15 Publication of EE200300096A publication Critical patent/EE200300096A/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Hematology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Toxicology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EEP200300096A 2000-09-12 2001-09-07 Arginiini ja selle farmatseutiliselt vastuvõetavate soolade kasutamine, antineoplastilist toimeainet ja arginiini sisaldava intravenoosselt manustatava preparaadi kasutamine, toode või komplekt kasutamiseks vähiravis ja preparaat intravenoosseks manu EE200300096A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2000MI001984A IT1318689B1 (it)	2000-09-12	2000-09-12	Uso dell'arginina nella preparazione di un medicamento per lapreparazione e trattamento degli effetti collaterali associati alla
PCT/EP2001/010398 WO2002022134A1 (en)	2000-09-12	2001-09-07	Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals

Publications (1)

Publication Number	Publication Date
EE200300096A true EE200300096A (et)	2005-02-15

Family

ID=11445780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300096A EE200300096A (et)	2000-09-12	2001-09-07	Arginiini ja selle farmatseutiliselt vastuvõetavate soolade kasutamine, antineoplastilist toimeainet ja arginiini sisaldava intravenoosselt manustatava preparaadi kasutamine, toode või komplekt kasutamiseks vähiravis ja preparaat intravenoosseks manu

Country Status (23)

Country	Link
US (1)	US20040014693A1 (et)
EP (1)	EP1318817A1 (et)
JP (1)	JP2004508406A (et)
KR (1)	KR20030045066A (et)
CN (1)	CN1466458A (et)
AR (1)	AR030635A1 (et)
AU (1)	AU2002214974A1 (et)
BR (1)	BR0113844A (et)
CA (1)	CA2421920A1 (et)
CZ (1)	CZ2003957A3 (et)
EA (1)	EA200300368A1 (et)
EE (1)	EE200300096A (et)
HU (1)	HUP0301026A2 (et)
IL (1)	IL154754A0 (et)
IT (1)	IT1318689B1 (et)
MX (1)	MXPA03002114A (et)
NO (1)	NO20031115D0 (et)
NZ (1)	NZ524677A (et)
PE (1)	PE20020432A1 (et)
PL (1)	PL361844A1 (et)
SK (1)	SK4562003A3 (et)
WO (1)	WO2002022134A1 (et)
ZA (1)	ZA200302866B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080249001A1 (en) *	2006-10-25	2008-10-09	Ajinomoto Co. Inc.	Agents that alleviate side-effects caused by chemotherapy agents
WO2022072885A1 (en)	2020-10-02	2022-04-07	Lupagen, Inc.	Closed loop, bedside cell purification systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5602112A (en) *	1992-06-19	1997-02-11	Supergen, Inc.	Pharmaceutical formulation
US5780446A (en) *	1996-07-09	1998-07-14	Baylor College Of Medicine	Formulations of vesicant drugs and methods of use thereof
GB9921960D0 (en) *	1999-09-16	1999-11-17	Pharmacia & Upjohn Spa	Formulations for parenteral use of estramustine phosphate and amino acids
US6436913B1 (en) *	2000-07-25	2002-08-20	Pharmacia & Upjohn Company	Use of estramustine phosphate in the treatment of bone metastasis

2000
- 2000-09-12 IT IT2000MI001984A patent/IT1318689B1/it active
2001
- 2001-09-07 SK SK456-2003A patent/SK4562003A3/sk unknown
- 2001-09-07 US US10/363,998 patent/US20040014693A1/en not_active Abandoned
- 2001-09-07 KR KR10-2003-7003557A patent/KR20030045066A/ko not_active Withdrawn
- 2001-09-07 IL IL15475401A patent/IL154754A0/xx unknown
- 2001-09-07 EE EEP200300096A patent/EE200300096A/et unknown
- 2001-09-07 CZ CZ2003957A patent/CZ2003957A3/cs unknown
- 2001-09-07 EP EP01983475A patent/EP1318817A1/en not_active Withdrawn
- 2001-09-07 BR BR0113844-8A patent/BR0113844A/pt not_active IP Right Cessation
- 2001-09-07 MX MXPA03002114A patent/MXPA03002114A/es not_active Application Discontinuation
- 2001-09-07 AU AU2002214974A patent/AU2002214974A1/en not_active Abandoned
- 2001-09-07 HU HU0301026A patent/HUP0301026A2/hu unknown
- 2001-09-07 NZ NZ524677A patent/NZ524677A/en unknown
- 2001-09-07 CA CA002421920A patent/CA2421920A1/en not_active Abandoned
- 2001-09-07 JP JP2002526384A patent/JP2004508406A/ja not_active Withdrawn
- 2001-09-07 CN CNA018165168A patent/CN1466458A/zh active Pending
- 2001-09-07 PL PL01361844A patent/PL361844A1/xx not_active Application Discontinuation
- 2001-09-07 EA EA200300368A patent/EA200300368A1/ru unknown
- 2001-09-07 WO PCT/EP2001/010398 patent/WO2002022134A1/en not_active Ceased
- 2001-09-10 AR ARP010104268A patent/AR030635A1/es unknown
- 2001-09-11 PE PE2001000911A patent/PE20020432A1/es not_active Application Discontinuation
2003
- 2003-03-11 NO NO20031115A patent/NO20031115D0/no unknown
- 2003-04-11 ZA ZA200302866A patent/ZA200302866B/en unknown

Also Published As

Publication number	Publication date
PE20020432A1 (es)	2002-05-11
ZA200302866B (en)	2004-04-28
ITMI20001984A1 (it)	2002-03-12
EP1318817A1 (en)	2003-06-18
EA200300368A1 (ru)	2003-08-28
ITMI20001984A0 (it)	2000-09-12
NO20031115L (no)	2003-03-11
KR20030045066A (ko)	2003-06-09
WO2002022134A8 (en)	2004-03-04
CN1466458A (zh)	2004-01-07
BR0113844A (pt)	2003-06-03
CA2421920A1 (en)	2002-03-21
NZ524677A (en)	2005-02-25
CZ2003957A3 (cs)	2003-09-17
US20040014693A1 (en)	2004-01-22
AR030635A1 (es)	2003-08-27
AU2002214974A1 (en)	2002-03-26
IT1318689B1 (it)	2003-08-27
HUP0301026A2 (hu)	2003-10-28
JP2004508406A (ja)	2004-03-18
MXPA03002114A (es)	2003-06-19
SK4562003A3 (en)	2003-09-11
IL154754A0 (en)	2003-10-31
WO2002022134A1 (en)	2002-03-21
PL361844A1 (en)	2004-10-04
NO20031115D0 (no)	2003-03-11

Publication	Publication Date	Title
NO2017047I1 (no)	2017-09-08	Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
CY1105707T1 (el)	2010-12-22	Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
DE60115029D1 (de)	2005-12-22	Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
AU2002239282A1 (en)	2002-06-11	Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
ATE514424T1 (de)	2011-07-15	Pharmazeutische zubereitungen von taxanen
AR029763A1 (es)	2003-07-16	Uso de una combinacion de una nsaid y un inhibidor de quinasa egfr para la manufactura de un medicamento para el tratamiento o inhibicion de polipos colonicos y cancer colorectal, composicion farmaceutica y medicamento
HUP0401174A3 (en)	2005-12-28	Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds
EE04997B1 (et)	2008-04-15	Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
MXPA03000753A (es)	2003-10-15	Derivados de benzimidazola, su preparacion y su aplicacion terapeutica.
AU4583601A (en)	2001-09-24	Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use
EE05109B1 (et)	2008-12-15	Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
CZ20023753A3 (cs)	2003-11-12	Substituované thioacetamidy, jejich použití pro výrobu léčiva a farmaceutický prostředek s jejich obsahem
DK1383752T3 (da)	2005-10-17	Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
IL159217A0 (en)	2004-06-01	An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
GB2368525B (en)	2004-08-11	Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
CY1106203T1 (el)	2011-06-08	Η χρηση της l-καρνιτινης και των αλκανοϋλο παραγωγων αυτης σαν ωσμωτικων παραγοντων σε διαλυματα για ιατρικη χρηση
AU2001264044A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
AU2001264042A1 (en)	2001-12-11	1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
ATE417608T1 (de)	2009-01-15	Arzneizusammensetzungen enthaltend modafinilverbindungen
AR036321A1 (es)	2004-09-01	Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
WO2003018535A3 (en)	2004-03-18	Novel aminobenzoephenones
HUP0303597A3 (en)	2006-03-28	Diposable vaginal cannula for the simultaneous administration of drugs in different forms
HRP20080597T3 (en)	2008-12-31	Cancer combination therapy comprising azd2171 and zd1839
HUP0201810A3 (en)	2004-12-28	Sootepenseone and its derivatives, their preparation and use as medicament
EE200200551A (et)	2004-04-15	Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine